- Home
- Industry Reports
- Healthcare
- Healthcare IT
- Global Genetic Testing System Market – Size, Outlook, Trends and Forecast (2024 – 2032)
Genetic Testing is also known as DNA testing that determines the bloodlines and the genetic diagnosis of vulnerabilities to inherited diseases. Progeny Testing, a form of genetic testing can be used to evaluate the quality of breeding stock. Genetic testing determines the genetic strengths and vulnerabilities of the species population.The global genetic testing market is expected to reach 6.5 billion dollars with a CAGR of 9.26% by 2024.
Global Genetic Testing Market Share:
The global genetic testing market is segmented on the basis of the testing type which is further categorised into Carrier Testing, Predictive and Presymptomatic Testing. Predictive and Presymptomatic Testing is higher in revenue specified in terms of Cancer Panel.
Global Genetic Testing Market Size:
North America is going to have the major share in the market followed by the Asia Pacific.Asia Pacific is going to be the fastest growing region and also going to maintain the highest CAGR percent in the forecast period.
Global Genetic Testing Market Growth:
The challenges like high cost of test and monetary obstructions due to the high cost of technology in production may hamper the growth of the market. The growing number of chronic diseases like cancer, Alzheimer’s. that drive the major growth in the market. The Asia Pacific, that includes several developing economies that acts as a better opportunity for gene testing in the forecast period.
Global Genetic Testing Market Industry Analysis:
The global genetic testing market is done by testing type, method type and by industry. In the category of Testing, we have Carrier testing, diagnostic testing and forensic testing. Diagnostic testing has the major application areas of genetic testing.
Global Genetic Testing Market Outlook:
North America is expected to register the highest share of the genetic testing market due to the presence of key players like Genentech and Oxford Biomedical in the biotechnology industry.On the other hand, Asia Pacific is going to be the fastest growing region for the genetic testing market.
Global Genetic Testing Market Trends:
Ranomics is building the world’s first comprehensive knowledge base of functionally-characterised genetic variants has on its protein’s biological function can provide strong proof to support classification. Biocartis targets to provide direct access to personalised medicine for patients globally by developing fully integrated and broadly applicable molecular diagnostics.
Global Genetic Testing Market Research Report includes:
- An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.
- To have complete market analysis through industry value chain analysis, Porter’s five, PESTLE, SWOT analysis, and Y-o-Y analysis.
- Regional and global diversity is analyzed with the major countries and the unions.
- Scrutinizing the revenue generation on Year–On–Year
- Identifying DROC in the current market and their impact in altering the market dynamics.
- Competitive landscape analysis to identify the merger and acquisition which will have a comparative financial analysis with major competitors.
- Expertise investment opportunities by an analyst to the individual and organization to have a better foothold in the market.
- Identify the latest developments, market shares and strategies that are employed by the major market players, such as
- Ranomics
- Applied Biosystems, Inc.
- Biocartis SA
- Daan Diagnostics Ltd
- Celera Group
Chapter 1 Introduction
1.1 Executive Summary
1.2 Market Definition
1.3 Scope of the Study
Chapter 2 Research Methodology
2.1 Secondary Research
2.2 Primary Research
2.3 Analytic Tools and Model
2.4 Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5 Expert Validation
2.6 Study Timeline
Chapter 3 Market Analysis
3.1 Industry Value Chain Analysis
3.2 Porter’s Five Analysis
3.2.1 Bargaining Power of Buyers
3.2.2 Bargaining Power of Suppliers
3.2.3 Threats of Substitutes
3.2.4 Threats of New Entrants
3.2.5 Industry Rivalry
3.3 Pestle Analysis
3.3.1 Political
3.3.2 Economical
3.3.3 Social
3.3.4 Technological
3.3.5 Legal
3.3.6 Environmental
3.4 SWOT Analysis
3.4.1 Strengths
3.4.2 Weakness
3.4.3 Opportunities
3.4.4 Threats
3.5 Y-O-Y Analyses
Chapter 4 Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 opportunities
4.4 constraints
Chapter 5 Market Segmentation Analysis
Chapter 6 Market Segmentation by Testing type
6.1 Introduction
6.2 Newborn Screening
6.3 Carrier Testing
6.4 Predictive and Presymptomatic Testing
6.4.1 Cancer Panel
6.4.2 BCRA
6.5 Forensic Testing
6.6 Diagnostic Testing
6.6.1 Liquid Biopsy
6.7 Prenatal Testing
6.7.1 NIPT
Chapter 7 Market Segmentation by Methods
7.1 Introduction
7.2 Chromosomal Genetic Testing
7.3 Biochemical Genetic Testing
7.4 Molecular Genetic Testing
Chapter 8 Market Segmentation by Testing Sample
8.1 Introduction
8.2 Blood
8.3 Saliva
8.4 Tumours
8.5 Hair
Chapter 9 Market Segmentation by Industry
9.1 Laboratories
9.2 Blood Banks
9.3 Nursing Homes
9.4 Hospitals
9.5 Others
Chapter 10 Market Segmentation by Geography
10.1 Asia Pacific
10.1.1 Introduction
10.1.2 China
10.1.3 India
10.1.4 Japan
10.1.5 Australia
10.1.6 Others
10.2 North America
10.2.1 Introduction
10.2.2 United States
10.2.3 Canada
10.2.4 Mexico
10.2.5 Others
10.3 Europe
10.3.1 Introduction
10.3.2 Spain
10.3.3 UK
10.3.4 France
10.3.5 Russia
10.3.6 Italy
10.3.7 Others
10.4 The Middle East and Africa
10.4.1 Introduction
10.4.2 South Africa
10.4.3 Middle East Countries
10.4.4 Others
10.5 South America
10.5.1 Introduction
10.5.2 Argentina
10.5.3 Brazil
10.5.5 Others
Chapter 11 Competitive Landscape
11.1 Mergers & Acquisitions, Joint Ventures, Collaborations, and Agreements
11.2 Market Share Analysis
11.3 Strategies Adopted By Top Companies
Chapter 12 Company Profiles
12.1 Analogic Corporation
12.1.1 Business Overview
12.1.2 Product portfolio
12.1.3 Key Strategy
12.1.4 Recent Developments
12.2 Ranomics
12.3 Applied Biosystems, Inc.
12.4 Biocartis SA
12.5 Daan Diagnostics Ltd
12.6 Celera Group
12.7 Genentech, Inc.
12.8 DNAFit
12.9Eastern Biotech
12.10Perkinelmer, Inc.
12.11Dna Consultants
12.12Qiagens N.V.
12.13Sorenson Genomics, LLC
12.14Myriad Genetics
12.15Transgenomic, Inc.
Chapter 13 Market Estimates and Forecast
13.1 Market Estimates and Forecast 2018-2024(USD Million)
13.1.1 Market Estimation and Forecast by Testing type 2018-2024 (USD Million)
13.1.2 Market Estimates and Forecast by Methods 2018-2024 (USD Million)
13.1.3 Market Estimates and Forecast by Testing Sample 2018-2024 (USD Million)
13.1.4 Market Estimates and Forecast by Industry 2018-2024 (USD Million)
13.1.5 Market Estimates and Forecast by Geography 2018-2024 (USD Million)
Chapter 14 Market Insights
14.1 Insights of Industry Experts
14.2 Analyst Opinion (Market Understanding)
14.3 Investment Opportunities
Chapter 15 Appendix
15.1 List of Tables
15.2 List of Figures
- Competitive Analysis in marketing and strategic management is an assessment of the strengths and weaknesses of current and potential competitors.
- Monitoring the external and internal factors which affect the market dynamics with the aid of PESTLE analysis.
- The Regional and Global Variety is taken care of in the report.
- Year on Year basis generation of revenue is studied.
- Porter's Five Forces analyze the intensity of competition in an industry and its profitability level.
- The overview and the sustainability of the market are analyzed through SWOT.
- DROC (Drivers, Restraints, Opportunities and Challenges) is recognized in the current market scenario and see how its effect on market dynamics.
- The segment-level analysis in terms of type and technology.
- The value chain analysis, value that's created and captured by a company is the profit margin.
- Value Created and Captured – Cost of Creating that Value = Margin
- An executive summary consists of the whole report and the outcome is been given in the report to have brief knowledge about the report.
- Basis on the depth of the study we approach using analytical tools
- Expertise investment opportunities are given after analyzing the market to give the organization and the individual to have perfect knowledge about the market.
Global Report
$2,700.00 – $8,100.00
- EUR: €2,489.86 - €7,469.57
- INR: ₹225,053.86 - ₹675,161.59
- AED: د.إ9,909.00 - د.إ29,727.00
- GBP: £2,133.43 - £6,400.30
Additional information
Report Type | Extensive Report, Miniature report, Snapshot Report |
---|---|
Licence | Single User License, Team License, Corporate License |
Genetic Testing is also known as DNA testing that determines the bloodlines and the genetic diagnosis of vulnerabilities to inherited diseases. Progeny Testing, a form of genetic testing can be used to evaluate the quality of breeding stock. Genetic testing determines the genetic strengths and vulnerabilities of the species population.The global genetic testing market is expected to reach 6.5 billion dollars with a CAGR of 9.26% by 2024.
Global Genetic Testing Market Share:
The global genetic testing market is segmented on the basis of the testing type which is further categorised into Carrier Testing, Predictive and Presymptomatic Testing. Predictive and Presymptomatic Testing is higher in revenue specified in terms of Cancer Panel.
Global Genetic Testing Market Size:
North America is going to have the major share in the market followed by the Asia Pacific.Asia Pacific is going to be the fastest growing region and also going to maintain the highest CAGR percent in the forecast period.
Global Genetic Testing Market Growth:
The challenges like high cost of test and monetary obstructions due to the high cost of technology in production may hamper the growth of the market. The growing number of chronic diseases like cancer, Alzheimer’s. that drive the major growth in the market. The Asia Pacific, that includes several developing economies that acts as a better opportunity for gene testing in the forecast period.
Global Genetic Testing Market Industry Analysis:
The global genetic testing market is done by testing type, method type and by industry. In the category of Testing, we have Carrier testing, diagnostic testing and forensic testing. Diagnostic testing has the major application areas of genetic testing.
Global Genetic Testing Market Outlook:
North America is expected to register the highest share of the genetic testing market due to the presence of key players like Genentech and Oxford Biomedical in the biotechnology industry.On the other hand, Asia Pacific is going to be the fastest growing region for the genetic testing market.
Global Genetic Testing Market Trends:
Ranomics is building the world’s first comprehensive knowledge base of functionally-characterised genetic variants has on its protein’s biological function can provide strong proof to support classification. Biocartis targets to provide direct access to personalised medicine for patients globally by developing fully integrated and broadly applicable molecular diagnostics.
Global Genetic Testing Market Research Report includes:
- An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.
- To have complete market analysis through industry value chain analysis, Porter’s five, PESTLE, SWOT analysis, and Y-o-Y analysis.
- Regional and global diversity is analyzed with the major countries and the unions.
- Scrutinizing the revenue generation on Year–On–Year
- Identifying DROC in the current market and their impact in altering the market dynamics.
- Competitive landscape analysis to identify the merger and acquisition which will have a comparative financial analysis with major competitors.
- Expertise investment opportunities by an analyst to the individual and organization to have a better foothold in the market.
- Identify the latest developments, market shares and strategies that are employed by the major market players, such as
- Ranomics
- Applied Biosystems, Inc.
- Biocartis SA
- Daan Diagnostics Ltd
- Celera Group
Chapter 1 Introduction
1.1 Executive Summary
1.2 Market Definition
1.3 Scope of the Study
Chapter 2 Research Methodology
2.1 Secondary Research
2.2 Primary Research
2.3 Analytic Tools and Model
2.4 Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5 Expert Validation
2.6 Study Timeline
Chapter 3 Market Analysis
3.1 Industry Value Chain Analysis
3.2 Porter’s Five Analysis
3.2.1 Bargaining Power of Buyers
3.2.2 Bargaining Power of Suppliers
3.2.3 Threats of Substitutes
3.2.4 Threats of New Entrants
3.2.5 Industry Rivalry
3.3 Pestle Analysis
3.3.1 Political
3.3.2 Economical
3.3.3 Social
3.3.4 Technological
3.3.5 Legal
3.3.6 Environmental
3.4 SWOT Analysis
3.4.1 Strengths
3.4.2 Weakness
3.4.3 Opportunities
3.4.4 Threats
3.5 Y-O-Y Analyses
Chapter 4 Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 opportunities
4.4 constraints
Chapter 5 Market Segmentation Analysis
Chapter 6 Market Segmentation by Testing type
6.1 Introduction
6.2 Newborn Screening
6.3 Carrier Testing
6.4 Predictive and Presymptomatic Testing
6.4.1 Cancer Panel
6.4.2 BCRA
6.5 Forensic Testing
6.6 Diagnostic Testing
6.6.1 Liquid Biopsy
6.7 Prenatal Testing
6.7.1 NIPT
Chapter 7 Market Segmentation by Methods
7.1 Introduction
7.2 Chromosomal Genetic Testing
7.3 Biochemical Genetic Testing
7.4 Molecular Genetic Testing
Chapter 8 Market Segmentation by Testing Sample
8.1 Introduction
8.2 Blood
8.3 Saliva
8.4 Tumours
8.5 Hair
Chapter 9 Market Segmentation by Industry
9.1 Laboratories
9.2 Blood Banks
9.3 Nursing Homes
9.4 Hospitals
9.5 Others
Chapter 10 Market Segmentation by Geography
10.1 Asia Pacific
10.1.1 Introduction
10.1.2 China
10.1.3 India
10.1.4 Japan
10.1.5 Australia
10.1.6 Others
10.2 North America
10.2.1 Introduction
10.2.2 United States
10.2.3 Canada
10.2.4 Mexico
10.2.5 Others
10.3 Europe
10.3.1 Introduction
10.3.2 Spain
10.3.3 UK
10.3.4 France
10.3.5 Russia
10.3.6 Italy
10.3.7 Others
10.4 The Middle East and Africa
10.4.1 Introduction
10.4.2 South Africa
10.4.3 Middle East Countries
10.4.4 Others
10.5 South America
10.5.1 Introduction
10.5.2 Argentina
10.5.3 Brazil
10.5.5 Others
Chapter 11 Competitive Landscape
11.1 Mergers & Acquisitions, Joint Ventures, Collaborations, and Agreements
11.2 Market Share Analysis
11.3 Strategies Adopted By Top Companies
Chapter 12 Company Profiles
12.1 Analogic Corporation
12.1.1 Business Overview
12.1.2 Product portfolio
12.1.3 Key Strategy
12.1.4 Recent Developments
12.2 Ranomics
12.3 Applied Biosystems, Inc.
12.4 Biocartis SA
12.5 Daan Diagnostics Ltd
12.6 Celera Group
12.7 Genentech, Inc.
12.8 DNAFit
12.9Eastern Biotech
12.10Perkinelmer, Inc.
12.11Dna Consultants
12.12Qiagens N.V.
12.13Sorenson Genomics, LLC
12.14Myriad Genetics
12.15Transgenomic, Inc.
Chapter 13 Market Estimates and Forecast
13.1 Market Estimates and Forecast 2018-2024(USD Million)
13.1.1 Market Estimation and Forecast by Testing type 2018-2024 (USD Million)
13.1.2 Market Estimates and Forecast by Methods 2018-2024 (USD Million)
13.1.3 Market Estimates and Forecast by Testing Sample 2018-2024 (USD Million)
13.1.4 Market Estimates and Forecast by Industry 2018-2024 (USD Million)
13.1.5 Market Estimates and Forecast by Geography 2018-2024 (USD Million)
Chapter 14 Market Insights
14.1 Insights of Industry Experts
14.2 Analyst Opinion (Market Understanding)
14.3 Investment Opportunities
Chapter 15 Appendix
15.1 List of Tables
15.2 List of Figures
- Competitive Analysis in marketing and strategic management is an assessment of the strengths and weaknesses of current and potential competitors.
- Monitoring the external and internal factors which affect the market dynamics with the aid of PESTLE analysis.
- The Regional and Global Variety is taken care of in the report.
- Year on Year basis generation of revenue is studied.
- Porter's Five Forces analyze the intensity of competition in an industry and its profitability level.
- The overview and the sustainability of the market are analyzed through SWOT.
- DROC (Drivers, Restraints, Opportunities and Challenges) is recognized in the current market scenario and see how its effect on market dynamics.
- The segment-level analysis in terms of type and technology.
- The value chain analysis, value that's created and captured by a company is the profit margin.
- Value Created and Captured – Cost of Creating that Value = Margin
- An executive summary consists of the whole report and the outcome is been given in the report to have brief knowledge about the report.
- Basis on the depth of the study we approach using analytical tools
- Expertise investment opportunities are given after analyzing the market to give the organization and the individual to have perfect knowledge about the market.
Our Clientele
Exclusive Benefits
Credibility and Transparency
We actively recruit consumers, business professionals, and hard-to-reach individuals as members of our research panels, and we build trusted, ongoing relationships with them. Thus we provide the complete list of primary and secondary data sources in the report to maintain the transparency and to assure the credibility.
Exhaustive Coverage
Detailed and extensive coverage in the geography.Survey consultation for brand tracking, concept testing, consumer behaviour, and more, we have you covered with market research services that scale to meet your needs.
Competitive Edge
Our reports cover most recent updates in the market till the date of the purchase. We identify, gather and timely deliver analysis on impact of unprecedented decisions of CXOs in COVID-19 catastrophe on many businesses, their clients and their clients' clients without additional cost.
Golden Opportunities
A comprehensive strategic sieve analysis of the market by our analysts and consultants, aided by AI tools helps us find the non-obvious, golden and emerging opportunities for you to evaluate.
Top-notch Reports Guaranteed
70% of our research is exclusive; no other research firm has the depth and breadth of our research.
Post Purchase Support
Post-purchase support is provided for all our reports, for three months from the date of purchase, where related queries will be answered within 24 business hours over telephone or email.